Search hospitals > California > Palo Alto
Byers Eye Institute at Stanford
Claim this profilePalo Alto, California 94303
Conducts research for Age-Related Macular Degeneration
Conducts research for Macular Degeneration
Conducts research for Near-sightedness
Conducts research for Glaucoma
Conducts research for Uveitis
44 reported clinical trials
8 medical researchers
Summary
Byers Eye Institute at Stanford is a medical facility located in Palo Alto, California. This center is recognized for care of Age-Related Macular Degeneration, Macular Degeneration, Near-sightedness, Glaucoma, Uveitis and other specialties. Byers Eye Institute at Stanford is involved with conducting 44 clinical trials across 87 conditions. There are 8 research doctors associated with this hospital, such as Theodore Leng, MD, Charles C Lin, MD, Andrea Kossler, and Prithvi Mruthyunjaya, MD.Area of expertise
1Age-Related Macular Degeneration
Stage I
CFI positive
Stage II
2Macular Degeneration
Stage I
CFI positive
Stage II
Top PIs
Theodore Leng, MDStanford Medicine Ophthalmology4 years of reported clinical research
Studies Macular Edema
Studies Muscle Swelling
4 reported clinical trials
3 drugs studied
Charles C Lin, MDStanford University7 years of reported clinical research
Studies Fuchs' Dystrophy
Studies Herpes Simplex
3 reported clinical trials
6 drugs studied
Andrea KosslerStanford University3 years of reported clinical research
Studies None
Studies Thyroid Eye Disease
2 reported clinical trials
2 drugs studied
Prithvi Mruthyunjaya, MDByers Eye Institute at Stanford University5 years of reported clinical research
Studies Melanoma
Studies Uveal Melanoma
1 reported clinical trial
1 drug studied
Clinical Trials running at Byers Eye Institute at Stanford
Glaucoma
Graves Disease
Visual Impairment
None
Thyroid Disease
Open-Angle Glaucoma
Retinal Disease
Radiation Retinopathy
Blindness
Necrotizing Scleritis
Topical Insulin
for Glaucoma
This trial is testing the safety of applying a special form of insulin directly to the eye in patients with optic nerve damage from conditions like glaucoma. The insulin may help heal and protect the damaged nerve cells. Insulin eyedrops have been shown to be feasible for lowering blood glucose in humans and have been tested for safety and efficacy in animal models.
Recruiting1 award Phase 1
Electrical Stimulation
for Glaucoma
The purpose of the study is to evaluate the efficacy, transorbital alternating current stimulation (rtACS) using the EYETRONIC for the treatment in patients with glaucoma.
Recruiting0 awards N/A2 criteria
NT-501 Cell Therapy
for Glaucoma
This trial tests tiny devices that release a protective protein into the eyes of patients with glaucoma-related vision problems. The protein helps protect nerve cells, potentially preventing further vision loss and improving sight.
Recruiting0 awards Phase 213 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Byers Eye Institute at Stanford?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.